Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Before investing all your savings, evaluate your financial goals and risk tolerance. Make informed decisions to safeguard your future.
23,659 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A director sold 20,000 shares of First Merchants Corp in a move totaling about $835k. This article explains why insid...
Apple and Nvidia sit at the pinnacle of market caps, but they play very different roles in investors’ portfolios. Thi...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
This week brings four major earnings reports that could reveal trends in consumer spending, AI demand, and corporate ...
TJX has built a reputation as a reliable off-price retailer with durable demand. But for investors, does the premium...
When a founder sells a large chunk of stock, it can raise questions for investors. This article explains what best bu...
Tech names surged as AI infrastructure demand strengthens revenue outlook. This article breaks down what happened, wh...
Palantir has wowed investors with AI-enabled results, but its sky-high valuation raises questions. This guide uses hi...
Ford and GM are reshaping their business models by moving into energy-related assets like batteries, charging network...
This week, plug power stock rocketed about 20% as earnings and feasibility signals fed optimism about hydrogen adopti...
Investors are weighing AI-driven promises against advertising risks as Alphabet and META steer big bets into the futu...